Drugs / Bone Marrow Stem Cells
Bone Marrow Stem Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT01518842 | Sep 2011 → Oct 2018 | ischemic disease | University of Sao Paulo | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01065337 Comparator | Aug 2005 → Feb 2009 | — | Ruhr University of Bochum | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01065337 ↗ |
| Known as | BMC | “bone marrow stem cells (BMC)” NCT01065337 ↗ |
| Known as | BMMSC | “One intravitreal injection of a 0.1-ml cell suspension containing around 10x106 bone marrow mononuclear stem cells(BMMSC).” NCT01518842 ↗ |
| Modality | Cell therapy | “Bone marrow mononuclear cells (BMCs)” PMID 22284892 ↗ Jan 2012 |
| Route | Other | “bone marrow stem cells administered intraarterial” NCT01065337 ↗ |